PAML CEO Velazquez to step down

Tuesday, June 20, 2017

(as reported in the Journal of Business Morning Edition)

Pathology Associates Medical Laboratories President and CEO Francisco Velazquez said he's stepping down from that position, effective June 30. Velazquez, who has led PAML for 5 1/2 years, said he will pursue "other opportunities in the broader life sciences and health care industries." His decision comes about four months after North Carolina-based LabCorp. agreed to acquire PAML.